These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1015018)

  • 1. [A new possibility of "non-parenteral" (local) vaccination: immunization per wound (author's transl)].
    Baljer G; Meiler H; Sailer J; Mayr A
    Zentralbl Bakteriol Orig A; 1976 Nov; 236(2-3):308-15. PubMed ID: 1015018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental investigations on oral immunization with tetanus-toxoid (author's transl)].
    Baljer G; Starflinger H; Sorg KH; Sailer J; Mayr A
    Zentralbl Bakteriol Orig A; 1975 Aug; 232(4):488-98. PubMed ID: 1199521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral immunization against tetanus.
    Baljer G
    Dev Biol Stand; 1976; 33():63-71. PubMed ID: 955281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental investigations on the immunity development in irradiated mice after local and parenteral immunization with tetanus-toxoid (author's transl)].
    Baljer G; Schaller M; Schick P; Sailer J; Messerschmidt O; Mayr A
    Strahlentherapie; 1977 Sep; 153(9):638-44. PubMed ID: 906051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled field trials with oral and nasal immunization against tetanus in humans.
    Mayr A; Baljer G; Baljer E; Sailer J
    Dev Biol Stand; 1978; 41():31-8. PubMed ID: 753660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serological study carried out in Cambodia during a tetanus vaccination in adults].
    Schlumberger M; Yvonnet B; Que HV; Chhem DB; Saliou P; Le Tu TC; Glaziou P
    Bull Soc Pathol Exot; 2008 Feb; 101(1):36-42. PubMed ID: 18432006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel fusogenic vesosomes for transcutaneous immunization.
    Mishra V; Mahor S; Rawat A; Dubey P; Gupta PN; Singh P; Vyas SP
    Vaccine; 2006 Jul; 24(27-28):5559-70. PubMed ID: 16730102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of a numerically additive combined vaccine against tetanus and smallpox].
    Mayr A; Baljer G; Wagner C; Sailer J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):206-18. PubMed ID: 2990123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radioprotective effectiveness of the paramunity inducer "pind-avi": investigation using the model "protective tetanic vaccination in mice" after exposure to X-rays (author's transl)].
    Mayr A; Baljer G; Sailer J; Schels D
    Strahlentherapie; 1980 Nov; 156(11):795-9. PubMed ID: 6254210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetanus toxoid-loaded transfersomes for topical immunization.
    Gupta PN; Mishra V; Singh P; Rawat A; Dubey P; Mahor S; Vyas SP
    J Pharm Pharmacol; 2005 Mar; 57(3):295-301. PubMed ID: 15807984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current trends in the use of combined serum and vaccine in tetanus prevention].
    Olivo R; Fabio U
    Boll Ist Sieroter Milan; 1980 Nov; 59(5):455-63. PubMed ID: 7248074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of neonatal tetanus: 1995.
    Sokhey J
    J Commun Dis; 1991 Mar; 23(1):1-10. PubMed ID: 1918863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental cost-effectiveness of supplementary immunization activities to prevent neonatal tetanus in Pakistan.
    Griffiths UK; Wolfson LJ; Quddus A; Younus M; Hafiz RA
    Bull World Health Organ; 2004 Sep; 82(9):643-51. PubMed ID: 15628201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant.
    Naito S; Maeyama J; Mizukami T; Takahashi M; Hamaguchi I; Yamaguchi K
    Vaccine; 2007 Dec; 25(52):8762-70. PubMed ID: 18023509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental study upon the efficacy of some accelerated vaccination schedules in tetanus prophylaxis.
    Dimache G; Croitoru M; Durbaca S; Stoean C; Dimache A
    Roum Arch Microbiol Immunol; 1993; 52(4):247-54. PubMed ID: 7827361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate tetanus prophylaxis practices in patients attending Emergency Departments in Italy.
    Abbate R; Di Giuseppe G; Marinelli P; Angelillo IF;
    Vaccine; 2008 Jul; 26(29-30):3634-9. PubMed ID: 18538902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of neonatal tetanus in India.
    Sokhey J; Bhargava I
    Indian Pediatr; 1984 Jul; 21(7):515-9. PubMed ID: 6519778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis.
    Robinson K; Chamberlain LM; Schofield KM; Wells JM; Le Page RW
    Nat Biotechnol; 1997 Jul; 15(7):653-7. PubMed ID: 9219268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-frequency ultrasound as a transcutaneous immunization adjuvant.
    Tezel A; Paliwal S; Shen Z; Mitragotri S
    Vaccine; 2005 May; 23(29):3800-7. PubMed ID: 15893617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.